Results 111 to 120 of about 149,298 (164)

Engineering pyroptotic vesicles as personalized cancer vaccines. [PDF]

Nat Nanotechnol
Li Z, Wang Y, Mo F, Wolter T, Hong R, Barrett A, Richmond N, Liu F, Chen Y, Yang X, Dempsey L, Hu Q.   +11 more
europepmc   +1 more source

Strategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines. [PDF]

Int J Mol Sci
Wu J, Liang J, Zhang Y, Dong C, Tan D, Wang H, Zheng Y, He Q.   +7 more
europepmc   +1 more source

Personalized Cancer Vaccines in Combination Therapies: Current Status and Future Prospects. [PDF]

Asian Pac J Cancer Prev
Rukhayya F, Katta L, Ghori HK, Kattela S, Parvez M, Posani S, Parmar MP, Jatin F, Sahu S, Younas S.   +9 more
europepmc   +1 more source

Therapeutic Colorectal Cancer Vaccines: Emerging Modalities and Translational Opportunities. [PDF]

Vaccines (Basel)
Muthukutty P, Woo HY, Yoo SY.
europepmc   +1 more source

Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy. [PDF]

Explor Target Antitumor Ther
Anilkumar AS, Thomas SM, Veerabathiran R.   +2 more
europepmc   +1 more source

Harnessing immunotherapy: cancer vaccines as novel therapeutic strategies for brain tumor. [PDF]

Front Immunol
Kiel K, Piranlioglu R, Godlewski J, Bronisz A.   +3 more
europepmc   +1 more source

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines

Zitvogel L, Carrier A, Manghi P, Silva CAC, Lahmar I, Birebent R, Suissa D, Laheurte C, Schreibelt G, Lemant L, FAHRNER J, de Sousa E, Berthier F, Villemonteix J, Chevalier M, Piccinno G, Hocquet D, Lebhar I, Maeurer M, Caillat-Zucman S, Kroemer G, Derosa L, Launay O, Golden E, Bol K, De Vries IJM, Adotévi O, Segata N, Formenti S, Kobold S, Pieper D, Vital M, Santos-Peral A, Zaucha M, García-Bengoa M, Thorn-Seshold J, Stirling H, Rothenfusser S, Iebba V, Almonte A, Ajami N, White M, Sahasrabhojane P, Hoballah Y, Losh J, DePinho C, Dondossola E, Wargo J.   +47 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cancer Vaccines

Current Protocols in Human Genetics, 1997
AbstractThis unit describes the use of retroviral vectors that can be successfully employed for gene transfer into both primary tumor cultures and established cell lines. The unit includes procedures for assaying the stability of the vaccine following gene transfer.
T F, Greten, E M, Jaffee
  +8 more sources

Cancer vaccines

Seminars in Oncology Nursing, 2003
To provide a review of cancer vaccines, how they work, and the current state of the science underlying these treatments.Research studies, review articles, book chapters, personal communications.Vaccines have been studied in a variety of malignancies; however, melanoma has provided the best tumor model for vaccination.
Paula M, Muehlbauer, Douglas J, Schwartzentruber   +1 more
openaire   +4 more sources

Cancer vaccines

Vaccine, 2001
Cancer vaccines have been extensively tested in animal models, and in humans. Initial studies focused on first generation vaccines based on whole cell preparations or tumor lysates derived from autologous or allogeneic tumors. Clinical studies conducted with such candidate vaccines contributed to establish the feasibility of immunizing cancer patients ...
R F, Rousseau, C, Hirschmann-Jax, S, Takahashi, M K, Brenner   +3 more
openaire   +4 more sources